Convexity Labs

DSAC

Convexity Analyst · DSAC
low confidenceTactical · no named thesis
Generated Jun 21, 2026

ANALYST NOTE: DSAC (Daedalus Special Acquisition Corp.) Date: 2026-06-13 Price: $10.07

1. Structural Readiness

  • State: Context-Only.
  • Conservative Entry: Not applicable (No breakout confirmed).
  • Aggressive/Pre-Breakout Entry: Not actionable on setup alone; requires a confirmed target announcement or a sustained close above the consolidation range (typically >$10.50-$11.00 depending on market sentiment).
  • Breakout Level: Pending announcement of a definitive business combination agreement.
  • Current Price: $10.07.
  • Extension: 0.7% above the $10.00 floor.
  • ATR Context: Current ATR is 1.0% (sub-threshold). This indicates low volatility and a lack of directional conviction in the market for this name prior to a deal announcement.

2. Thesis Layer

  • Thesis Classification: TACTICAL / SETUP-LED.
  • Macro Thesis: There is NO named secular macro thesis active for DSAC as of 2026-06-13. While the management team has historically articulated a focus on "Consumer AI" (see Evidence E6-E10), this is a *target selection strategy*, not a current operating thesis for the SPAC vehicle itself.
  • Judgment Criteria: The investment case must be judged strictly on the quality of the setup (price holding above the floor), the credibility of the management team's ability to close a deal, and the fundamentals of the eventual target. Do not invent a macro thesis; the name is currently a vehicle waiting for a catalyst.

3. Business Fundamentals

  • Business Model: DSAC is a blank-check company (SPAC) organized for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more target businesses.
  • Operations: As of March 31, 2026, the Company has not commenced any operations (Evidence E3). It generates no revenue and holds no operating assets other than cash in a trust account.
  • Target Strategy: Management's stated strategy is to capitalize on the "consumer artificial intelligence (AI)" platform shift (Evidence E6). They intend to acquire a leading consumer AI company operating at large scale with a profitable subscription-driven model (Evidence E10).
  • Financial Constraints:
  • 80% Test: Nasdaq rules and the company's charter require any business combination to have a fair market value of at least 80% of the net balance in the Trust Account (Evidence E1, E11).
  • Timeline: The company has until 24 months from the IPO closing to consummate a combination, or until an earlier liquidation date approved by the board (Evidence E5).
  • Market Context: Management cites global market volatility and geopolitical instability (Russia-Ukraine, Middle East conflicts) as the backdrop for their investment environment (Evidence E4).

4. Archetype and Conviction

  • Archetype: Structural Speculative / Deep Value Recovery (Conditional).
  • *Fit:* This is not a "Quality Compounder" or "Growth Leader" in the traditional sense because it has no operations. It is a "Deep Value" play only in the sense that the price ($10.07) is anchored to the trust value ($10.00+), offering a theoretical floor. It is a "Structural Speculative" vehicle because the upside is binary: either a successful merger with a high-growth AI target or liquidation.
  • Valuation Context: The valuation is effectively the Trust Account value. There is no P/E or P/S multiple to analyze as the company has no earnings or revenue.
  • Conviction Stack:
  • *Thesis Strength:* Low (No deal announced).
  • *Evidence Quality:* Moderate (Clear rules on the 80% test and timeline, but no target data).
  • *Setup Readiness:* Low (ATR is sub-threshold at 1.0%; no breakout signal).
  • *Rerating Potential:* High *if* a target is announced, but currently zero.
  • ATR Analysis: The current ATR of 1.0% is sub-threshold (<2.5%). This confirms the "Forming" state: the market is dormant. Historically, setups with sub-threshold ATR require a significant catalyst (deal announcement) to expand volatility and trigger a breakout.

5. Invalidation, Strengthening, and Gaps

  • What Would Invalidate:
  • A closing price below $10.00 (Trust Floor).
  • A shareholder vote to extend the deadline that fails, leading to liquidation.
  • A public announcement that the company is abandoning the Consumer AI thesis or has no viable targets.
  • What Would Strengthen:
  • Announcement of a Letter of Intent (LOI) or definitive agreement with a specific Consumer AI target.
  • Confirmation that the target meets the 80% Fair Market Value test (Evidence E1).
  • Extension of the deadline with strong shareholder approval, signaling confidence in the pipeline.
  • Gaps in Evidence:
  • Missing Target Data: There is no evidence of a specific target company, its revenue, margins, or unit economics.
  • Missing Trust Balance: The exact dollar amount in the Trust Account is not provided in the evidence, making the precise 80% threshold calculation impossible.
  • Missing Management Track Record: No evidence is provided regarding the specific experience of the board or management in closing AI deals.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: low Key evidence: Price holding at $10.07 above the $10.00 trust floor; Management strategy explicitly targets Consumer AI with a subscription model; Nasdaq 80% fair market value test provides a structural floor for deal size. Key risks: No operations or revenue as of March 31, 2026; High probability of liquidation if no deal is announced within the 24-month window; Sub-threshold ATR (1.0%) indicates lack of market conviction; Geopolitical volatility may delay deal execution. Sizing hint: Position size should be minimal, treated as an option-like exposure to a binary event; do not size based on conviction in the business, but on the probability of a deal closing. Expected path: Management will likely continue to search for a target; if a target is identified, the stock will likely gap up on the announcement; if no target is found by the deadline, the stock will converge to the trust value and liquidate. Expected horizon: 6 to 18 months (aligned with the remaining time in the completion window). Failure mode to watch: A sustained close below $10.00 or a public announcement of liquidation.

Loading chart...
Exhibit 1: DSAC daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for DSAC.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for DSAC.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: